| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/19/2007 | EP1833313A2 Compositions containing high omega-3 and low saturated fatty acid levels |
| 09/19/2007 | EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/19/2007 | EP1511719B1 Amide derivatives as inhibitors of the enzymatic activity of renin |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1490335B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/19/2007 | CN101039665A Composition containing omega-3 fatty acids and omega-6 fatty acids |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN101036752A Chinese traditional medicine composition |
| 09/19/2007 | CN100338219C Tissue specific expression of retinoblastoma protein |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100337638C Eye medicine prepn of effective shellfish component and its use |
| 09/19/2007 | CN100337621C Application of aspartic acid and its salt |
| 09/18/2007 | US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | CA2414680C Methods for treating inflammation-mediated conditions of the eye |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2243234C 5h-thiazolo[3,2-a]pyrimidine derivatives |
| 09/13/2007 | WO2007103960A1 Ocular therapy using sirtuin-activating agents |
| 09/13/2007 | WO2007103765A2 Treatment with cyclosporin a |
| 09/13/2007 | WO2007102724A2 Effects of the photoelectrolysing property of melanines, analogues thereof and derivatives thereof on cell biology, and use thereof for various purposes |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102392A1 Mmp-13-selective inhibitor |
| 09/13/2007 | WO2007102008A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | WO2007067981A3 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/13/2007 | WO2006024627A3 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | CA2646882A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2644241A1 Treatment with cyclosporin a |
| 09/13/2007 | CA2643903A1 Ocular therapy using sirtuin-activating agents |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1830853A2 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/12/2007 | EP1830848A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 09/12/2007 | EP1830807A1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 09/12/2007 | EP1830803A2 Medicament for hygienic application inside the ear |
| 09/12/2007 | EP1526851B1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 09/12/2007 | EP1519962B1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
| 09/12/2007 | EP1406616B1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | CN101035530A VEGF inhibition |
| 09/12/2007 | CN101032683A Xanthin micro-capsule and the preparing method |
| 09/12/2007 | CN101032550A Medicine combination for curing diabetes and complication thereof and the preparing method and purpose |
| 09/12/2007 | CN101032529A Prepn. technique for Chinese traditional medicine ophthalmic gel |
| 09/12/2007 | CN100336567C Medical cornea paster and its preparation method |
| 09/12/2007 | CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268145 Thiobenzimidazole derivatives |
| 09/11/2007 | US7268141 Xanthine phosphodiesterase V inhibitors |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7267973 Nucleic acids encoding recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor |
| 09/11/2007 | CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 09/11/2007 | CA2200760C Aqueous compositions containing ciprofloxacine, and related use and process |
| 09/07/2007 | WO2007101204A1 Method of treating glaucoma |
| 09/07/2007 | WO2007101005A2 Compositions and methods for effecting controlled posterior vitreous detachment |
| 09/07/2007 | WO2007100566A2 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 09/07/2007 | WO2007100079A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative |
| 09/07/2007 | WO2007098520A1 Process for the manufacture of a composition containing at least one xanthophyll |
| 09/07/2007 | WO2007071733A3 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| 09/07/2007 | WO2006079217A8 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 09/07/2007 | CA2645123A1 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 09/07/2007 | CA2644810A1 Prophylactic or therapeutic agents for allergic ophthalmic diseases or allergic nasal diseases, comprising tricyclic triazolobenzazepine derivative |
| 09/07/2007 | CA2643320A1 Modulators of muscarinic receptors |
| 09/07/2007 | CA2643282A1 Compositions and methods for effecting controlled posterior vitreous detachment |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070207153 Therapeutic Agents For Inner Ear Disorders Containing An Il-6 Antagonist As An Active Ingredient |
| 09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/06/2007 | DE102006009889A1 Topical product, useful for the prevention of eye irritation, and for prevention and treatment of blepharitis, comprises cobalamin in the form of cyano-, hydroxy- and/or methyl-cobalamin |
| 09/05/2007 | EP1829888A1 Anti-inflammatory compounds and uses thereof |
| 09/05/2007 | EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same |
| 09/05/2007 | EP1828148A1 Triazole substituted aminobenzophenone compounds |
| 09/05/2007 | EP1827602A1 Modulating retinal pigmented epithelium permeaion by inhibiting or activating vegfr-1 |
| 09/05/2007 | EP1827498A2 Stabilisation of glucocorticoid esters with acids |
| 09/05/2007 | EP1827417A1 Enhanced occlusive effect photodynamic therapy |
| 09/05/2007 | EP1827407A2 Methods, assays and compositions for treating retinol-related diseases |
| 09/05/2007 | EP1827406A1 Anti-radical agents |
| 09/05/2007 | EP1827403A2 Compositions for treating surface ocular pathologies |
| 09/05/2007 | EP1827373A2 Ophthalmic emulsions containing prostaglandins |
| 09/05/2007 | EP1511507B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | CN101031310A Ophthalmic composition containing xanthan gum and amino acid |
| 09/05/2007 | CN101031297A Pharmaceutical composition for xerophthalmia and xerostomia treatment |
| 09/05/2007 | CN101029338A Determination of risk factors for cataract by aldose reductase genotype |
| 09/05/2007 | CN101028512A Use of matrix metal protease inhibitor in preparation of medicine for treating nearsightedness |
| 09/05/2007 | CN101028487A Chinese-medicinal preparation for treating eyeground bleeding and method for inspecting vision-improving prescription quality |
| 09/05/2007 | CN101028459A Oral Chinese-medical composition for treating chronic otitis media |
| 09/05/2007 | CN101028446A Medicine for symptomatic dry eye |
| 09/05/2007 | CN101028424A Ercong suppository |
| 09/05/2007 | CN101028388A Quality inspection of Chinese-medicinal preparation for treating shortsighness and asthenopia |
| 09/05/2007 | CN101028368A Medicinal use of radix rehmanniae polyose and its production |
| 09/05/2007 | CN101028240A Micro-emulsion/submicro-emulsion in-situ gel preparation for eyes and its making method |
| 09/05/2007 | CN101028138A Health-care cigarette |
| 09/05/2007 | CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/05/2007 | CN100335064C Pueraria flavone micro pill prepn and its prepn process |